Navigation Links
Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
Date:11/9/2007

ng innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This release contains forward-looking statements, including summary statements relating to the interim or preliminary results of clinical trials involving Amrubicin. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause the final results to differ significantly from the results summarized by such statements. Preliminary results may not be confirmed upon final analysis of the detailed results of a trial and additional information relating to the safety, efficacy or tolerability of Amrubicin may be discovered upon further analysis of clinical trial data and upon review and analysis of additional clinical trial data from this or other clinical trials. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Pharmion also disclaims any duty to comment upon or correct information that may be contained in reports published by the inves
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
6. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
7. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
8. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
9. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  Dr. Mark Rasak , ... Diamond Lifetime Achievement Award in the field of Medicine ... Cardiovascular Clinical Associates. Dr. Rasak has over ... major aspects of the business; overseeing the daily operations; ... coronary intervention. In addition, he is an honored Fellow ...
(Date:8/22/2014)... , Aug. 22, 2014   Zacks Equity Research ... Bull of the Day and Panera (Nasdaq: PNRA - Free ... Equity Research provides analysis on Amicus Therapeutics (Nasdaq: FOLD - ... and Shire (Nasdaq: SHPG - Free Report ). ... Bull of the Day : The biotech ...
(Date:8/22/2014)... , Aug. 22, 2014  Mark Riccio, ... (CT) imaging facility, is using the online crowd-funding ... even 5D imaging to researchers and would-be superheros ... asks "What would YOU do if you had ... to researchers and explorers everywhere, from elementary through ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2
... Reportlinker.com announces that a new market research ... Process Analytical Technologies for Pharmaceuticals: Global Markets ... The global market for process analytical technology (PAT) ... 2010. This market is expected to increase by ...
... -- China Medicine Corporation (OTC Bulletin Board: ... distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and ... today announced that it has filed with the United ... on Form 8-K to disclose that its previously issued ...
Cached Medicine Technology:Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 2Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 3Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 4Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 5Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 6Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 7Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 8Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 9Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 10Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 11Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 12Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 13Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 14Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 15China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing 2China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing 3
(Date:8/22/2014)... With the stage set for the National Association ... which will be held in Boston August 23-26 - ... online opinion section, Podium. The op-ed “ To ... Steven C. Anderson, IOM, CAE, president & CEO of ... University School of Pharmacy – Worcester/Manchester. , Offered ...
(Date:8/22/2014)... 2014 Millennium Treatment Group has recently noticed ... high level of drug use among teenagers. The treatment facility ... addiction and work to minimize drug abuse. , America is ... drug addiction in history. According to the National Institute ... Americans aged 12 or older—or 9.2 percent of the population—had ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The regional ... Toyota Indiana is on the grow again. ... jobs by summer 2016 to boost production of the ... bring Toyota Indiana’s overall investment to $4 billion. This ... America while providing additional flexibility to adjust its product ...
(Date:8/22/2014)... (PHILADELPHIA) - A Penn Medicine team has found ... significantly reduce urinary tract infections in hospital patients ... of the alert was simplified, the rate of ... decide whether their patients need urinary catheters in ... reassess the need for catheters that have not ...
(Date:8/22/2014)... 22, 2014 (HealthDay News) -- Many Americans know little about ... possibility of an outbreak in the United States, a new ... are worried that there will be a major Ebola outbreak ... or an immediate family member will get sick with the ... Harvard School of Public Health poll. However, those opinions ...
Breaking Medicine News(10 mins):Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2
... Today at the 6th International AIDS Society ... the Drugs for Neglected Diseases initiative (DNDi) announced ... to address critical unmet treatment needs of children ... young children has largely been eliminated in high-income ...
... of Chemistry and NYU Langone Medical Center have developed ... in many types of cancer. The compound is described ... Chemical Biology. The researchers examined signaling ... a major underlying cause of various developmental disorders and ...
... , SATURDAY, July 16 (HealthDay News) -- As you ... in mind. The sun on your skin may feel nice, ... one major sunburn when they were a child or teen have ... kind of skin cancer, later in life, according to the Skin ...
... research conducted at Harvard Medical School and the Harvard ... informing the controversial debate currently surrounding national health care ... edition of the American Journal of Preventive Medicine, ... Aakanksha Pande, a doctoral student in the Department of ...
... taking certain antidepressant medications are at an increased risk of ... prescription or a dose increase of their current drug, according ... of Hebrew SeniorLife, an affiliate of Harvard Medical School., Published ... the study found that nursing home residents have a fivefold ...
... , FRIDAY, July 15 (HealthDay News) -- The ... reactions to small amounts of alcohol, a new study finds. ... 20s after they drank a small amount of red wine ... the wine, participants, left ventricular function decreased, according to the ...
Cached Medicine News:Health News:DNDi launches new drug development program to address treatment needs of children with HIV/AIDS 2Health News:DNDi launches new drug development program to address treatment needs of children with HIV/AIDS 3Health News:Massachusetts health-care reform increased access to care, particularly among disadvantaged 2Health News:Nursing home residents at heightened risk of falling in the days following 2Health News:Alcohol Affects Left, Right Heart Chambers Differently 2
... utilize Linvatecs exclusive Shockflex prism system to ... Using the latest technology, our 3CCD Camera ... and brightness. The Camera Heads are available ... configured with a number of optical couplers ...
... an integrated coupler can be steam sterilized using ... it is cool to the touch and ready ... Smarthead technology allowing each head to store procedure ... head has been used is displayed on the ...
... invasive surgery is founded on superior medical ... of 3-Chip cameras, 1-Chip cameras, Light sources, ... your demanding needs., ,Superior resolution and ... our 3-Chip cameras, and are the benchmark ...
... high-resolution 1-Chip Camera System provides easy-to-use features, ... small scope. The camera head construction is ... ,Complete 1-Chip Camera System for Microscopic Application, ... Camera Control Unit (CCU) with power cord ...
Medicine Products: